• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Prognosis prediction model for hepatocellular carcinoma based on autophagy related genes].基于自噬相关基因的肝细胞癌预后预测模型
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2022 Feb 25;39(1):120-127. doi: 10.7507/1001-5515.202101090.
2
Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients.鉴定一个与自噬相关的基因特征,可以改善肝癌患者的预后。
BMC Cancer. 2020 Aug 17;20(1):771. doi: 10.1186/s12885-020-07277-3.
3
ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.ATIC 通过 AKT/FOXO3 通路抑制肝癌中的自噬,并作为预测患者生存模型的预后特征。
Int J Biol Sci. 2021 Oct 25;17(15):4442-4458. doi: 10.7150/ijbs.65669. eCollection 2021.
4
Development and Validation of an Autophagy-Related Gene Signature for Predicting the Prognosis of Hepatocellular Carcinoma.自噬相关基因signature 预测肝细胞癌预后的建立和验证
Biomed Res Int. 2021 Oct 28;2021:7771037. doi: 10.1155/2021/7771037. eCollection 2021.
5
Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular Carcinoma.基于三个自噬相关基因的肝细胞癌预后模型的鉴定和验证。
Biomed Res Int. 2021 Mar 12;2021:5564040. doi: 10.1155/2021/5564040. eCollection 2021.
6
An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation.基于自噬相关基因的肝细胞癌预后风险签名:构建和验证。
Comput Math Methods Med. 2021 Oct 13;2021:5770228. doi: 10.1155/2021/5770228. eCollection 2021.
7
Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.基于凋亡相关基因挖掘亚洲肝细胞癌患者的预后标志物。
BMC Cancer. 2021 Feb 18;21(1):175. doi: 10.1186/s12885-021-07886-6.
8
Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma.基于自噬相关基因特征的肝细胞癌预后模型。
Biomark Med. 2020 Sep;14(13):1229-1242. doi: 10.2217/bmm-2020-0170.
9
Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma.鉴定一个自噬相关基因特征,可预测肝细胞癌的总生存期。
Biosci Rep. 2021 Jan 29;41(1). doi: 10.1042/BSR20203231.
10
Construction of a prognosis-predicting model based on autophagy-related genes for hepatocellular carcinoma (HCC) patients.构建基于自噬相关基因的肝细胞癌(HCC)患者预后预测模型。
Aging (Albany NY). 2020 Jul 18;12(14):14582-14592. doi: 10.18632/aging.103507.

本文引用的文献

1
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma.美国食品和药物管理局批准概要:阿替利珠单抗联合贝伐珠单抗用于治疗不可切除或转移性肝细胞癌患者。
Clin Cancer Res. 2021 Apr 1;27(7):1836-1841. doi: 10.1158/1078-0432.CCR-20-3407. Epub 2020 Nov 2.
2
BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells.BIRC5/Survivin 是一种新型 ATG12-ATG5 缀合相互作用蛋白,可作为人癌细胞和小鼠胚胎成纤维细胞中的自噬诱导性 DNA 损伤抑制剂。
Autophagy. 2020 Jul;16(7):1296-1313. doi: 10.1080/15548627.2019.1671643. Epub 2019 Oct 15.
3
New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.肝细胞癌自噬的新见解:机制与治疗策略
Am J Cancer Res. 2019 Jul 1;9(7):1329-1353. eCollection 2019.
4
A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients.一种用于胶质母细胞瘤患者生存预测的五基因风险分类系统。
Front Neurol. 2019 Jul 16;10:745. doi: 10.3389/fneur.2019.00745. eCollection 2019.
5
BIRC5 is a target for molecular imaging and detection of human pancreatic cancer.BIRC5 是人类胰腺癌分子成像和检测的靶点。
Cancer Lett. 2019 Aug 10;457:10-19. doi: 10.1016/j.canlet.2019.04.036. Epub 2019 May 3.
6
Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.自噬相关途径作为肝细胞癌的治疗靶点。
Expert Opin Ther Targets. 2019 May;23(5):393-406. doi: 10.1080/14728222.2019.1601703. Epub 2019 Apr 15.
7
Calpain-10 regulates actin dynamics by proteolysis of microtubule-associated protein 1B.钙蛋白酶-10 通过对微管相关蛋白 1B 的蛋白水解来调节肌动蛋白动力学。
Sci Rep. 2018 Nov 13;8(1):16756. doi: 10.1038/s41598-018-35204-x.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Tumor genetic analysis from single-cell RNA-seq data.来自单细胞RNA测序数据的肿瘤基因分析。
Nat Methods. 2018 Aug;15(8):571. doi: 10.1038/s41592-018-0089-9.
10
Mechanism and medical implications of mammalian autophagy.哺乳动物自噬的机制与医学意义。
Nat Rev Mol Cell Biol. 2018 Jun;19(6):349-364. doi: 10.1038/s41580-018-0003-4.

基于自噬相关基因的肝细胞癌预后预测模型

[Prognosis prediction model for hepatocellular carcinoma based on autophagy related genes].

作者信息

Huang Wei, Han Ning, Du Lingyao, Cao Dan, Tang Hong

机构信息

Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, P. R. China.

出版信息

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2022 Feb 25;39(1):120-127. doi: 10.7507/1001-5515.202101090.

DOI:10.7507/1001-5515.202101090
PMID:35231973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9927748/
Abstract

Autophagy is a programmed cell degradation process that is involved in a variety of physiological and pathological processes including malignant tumors. Abnormal induction of autophagy plays a key role in the development of hepatocellular carcinoma (HCC). We established a prognosis prediction model for hepatocellular carcinoma based on autophagy related genes. Two hundred and four differentially expressed autophagy related genes and basic information and clinical characteristics of 377 registered hepatocellular carcinoma patients were retrieved from the cancer genome atlas database. Cox risk regression analysis was used to identify autophagy-related genes associated with survival, and a prognostic model was constructed based on this. A total of 64 differentially expressed autophagy related genes were identified in hepatocellular carcinoma patients. Five risk factors related to the prognosis of hepatocellular carcinoma patients were determined by univariate and multivariate Cox regression analysis, including TMEM74, BIRC5, SQSTM1, CAPN10 and HSPB8. Age, gender, tumor grade and stage, and risk score were included as variables in multivariate Cox regression analysis. The results showed that risk score was an independent prognostic risk factor for patients with hepatocellular carcinoma ( = 1.475, 95% CI = 1.280-1.699, < 0.001). In addition, the area under the curve of the prognostic risk model was 0.739, indicating that the model had a high accuracy in predicting the prognosis of hepatocellular carcinoma. The results suggest that the new prognostic risk model for hepatocellular carcinoma, established by combining the molecular characteristics and clinical parameters of patients, can effectively predict the prognosis of patients.

摘要

自噬是一种程序性细胞降解过程,参与包括恶性肿瘤在内的多种生理和病理过程。自噬的异常诱导在肝细胞癌(HCC)的发生发展中起关键作用。我们基于自噬相关基因建立了肝细胞癌的预后预测模型。从癌症基因组图谱数据库中检索到240个差异表达的自噬相关基因以及377例注册肝细胞癌患者的基本信息和临床特征。采用Cox风险回归分析来识别与生存相关的自噬相关基因,并据此构建预后模型。在肝细胞癌患者中总共鉴定出64个差异表达的自噬相关基因。通过单因素和多因素Cox回归分析确定了5个与肝细胞癌患者预后相关的危险因素,包括跨膜蛋白74(TMEM74)、杆状病毒IAP重复序列5(BIRC5)、聚集体蛋白1(SQSTM1)、钙蛋白酶10(CAPN10)和热休克蛋白B8(HSPB8)。年龄、性别、肿瘤分级和分期以及风险评分作为多因素Cox回归分析中的变量。结果显示,风险评分是肝细胞癌患者的独立预后危险因素( = 1.475,95%可信区间 = 1.280 - 1.699, < 0.001)。此外,预后风险模型的曲线下面积为0.739,表明该模型在预测肝细胞癌预后方面具有较高的准确性。结果表明,结合患者的分子特征和临床参数建立的肝细胞癌新预后风险模型能够有效预测患者的预后。